Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer
Abroad (travel likely)RecruitingPHASE4
Conditions
Cervical Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Amsterdam UMC, Amsterdam, Netherlands
Contact: Principal Investigator (J. Tromp)Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands
Contact: Principal Investigator (M. A. Rijlaarsdam)Catharina Ziekenhuis, Eindhoven, Netherlands
Contact: Principal Investigator (A. M.J. Thijs)Medisch Spectrum Twente, Enschede, Netherlands
Contact: Principal Investigator (A. N.M. Wymenga)University Mecdical Center Groningen, Groningen, Netherlands
Contact: Principal Investigator (M. Jalving, MD, PhD)LUMC, Leiden, Netherlands
Contact: Principal Investigator (J. R. Kroep)Maastricht UMC, Maastricht, Netherlands
Contact: Principal Investigator (A. J.M. Beijers)Radboud UMC, Nijmegen, Netherlands
Contact: Principal Investigator (V. Soomers)Erasmus MC, Rotterdam, Netherlands
Contact: Principal Investigator (I. A. Boere)UMC Utrecht, Utrecht, Netherlands
Contact: Principal Investigator (I. O. Baas)Isala Klinieken, Zwolle, Netherlands
Contact: Principal Investigator (W. A. van der Steeg)
Study leads
M. Jalving
Principal Investigator
University Medical Center Groningen